微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 35.89% | -13.53% | -9.21% | 97/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 39.53% | 1.33% | -7.87% | 91/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 42.91% | 15.82% | 4.69% | 86/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 40.98% | 12.91% | -1.26% | 91/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 41.5% | 9.53% | 6.4% | 86/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 39.01% | 6.6% | 5.3% | 97/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 37.05% | 8.54% | 2.06% | 95/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 36.3% | 10.7% | -4.21% | 97/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 37.89% | -2.16% | 3.55% | 94/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 36.59% | -20.62% | 7.21% | 102/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 34.13% | -27.02% | 4.09% | 98/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 32.79% | -29.02% | -15.33% | 106/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 38.73% | -17.36% | -15.99% | 85/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 46.1% | 6.22% | -1.43% | 90/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 46.77% | 8.45% | 1.24% | 78/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 46.2% | 11.85% | -1.42% | 85/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 46.86% | 2% | 7.98% | 73/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 43.4% | -1.64% | 0.64% | 99/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 43.13% | 2% | 4.42% | 71/131 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 41.3% | 2% | -6.4% | 90/131 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 44.12% | -4.25% | -4.25% | 84/131 | 56.37% | 正海生物 | 94.38% | 行业排名> |
| 2018-12-31 | 46.08% | 9.26% | 9.26% | 68/131 | 55.53% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 42.18% | 2% | 2% | 69/131 | 55.34% | 正海生物 | 93.78% | 行业排名> |